These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 752592)

  • 41. Synergism between sodium chloride and sodium taurocholate and development of pepsinogen-altered pyloric glands: relevance to a medium-term bioassay system for gastric carcinogens and promoters in rats.
    Tatematsu M; Mutai M; Inoue K; Ozaki K; Furihata C; Ito N
    Jpn J Cancer Res; 1989 Nov; 80(11):1035-40. PubMed ID: 2514164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Changes in the content of pepsinogen messenger RNA in the gastric mucosa of rats during N-methyl-N'-nitro-N-nitrosoguanidine-induced carcinogenesis].
    Glebov AV; Kalinovskiĭ VP; Seĭts IF
    Eksp Onkol; 1986; 8(6):16-8. PubMed ID: 2433120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of histamine in changes which occur in the gastric mucosal barrier with bile damage.
    Rhodes J; Rees WD; Wheeler MH
    Scand J Gastroenterol Suppl; 1981; 67():79-81. PubMed ID: 6166037
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Establishment of Mongolian gerbil model of long-term Helicobacter pylori infection].
    Jin Z; Hu FL; Wei H; Tang XY; Dong Y
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1518-22. PubMed ID: 18956630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methylated analogues of prostaglandin E2 and the gastric mucosal barrier.
    Kenyon GS; Ansell IF; Carter DC
    Prostaglandins; 1978 May; 15(5):779-94. PubMed ID: 704903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kinetics of induction of DNA damage and lacZ gene mutations in stomach mucosa of mice treated with beta-propiolactone and N-methyl-N'-nitro-N-nitrosoguanidine, using single-cell gel electrophoresis and MutaMouse models.
    Brault D; Renault D; Tombolan F; Thybaud V
    Environ Mol Mutagen; 1999; 34(2-3):182-9. PubMed ID: 10529742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistence of gene expression changes in stomach mucosae induced by short-term N-methyl-N'-nitro-N-nitrosoguanidine treatment and their presence in stomach cancers.
    Yamashita S; Nomoto T; Abe M; Tatematsu M; Sugimura T; Ushijima T
    Mutat Res; 2004 May; 549(1-2):185-93. PubMed ID: 15120970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of topical isoproterenol on bile acid-induced gastric mucosal injury.
    Mercer DW; Podolsky RS; Ritchie WP; Dempsey DT
    Am Surg; 1993 Aug; 59(8):479-83. PubMed ID: 8338277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of gastrin on gastric mucosal cyclic adenosine 3':5'-monophosphate-dependent protein kinase activity in rat stomach carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine.
    Yasui W; Tahara E
    Cancer Res; 1985 Oct; 45(10):4763-7. PubMed ID: 4027963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of c-fos and c-myc oncogene expression in the pyloric mucosa of rat stomach by N-methyl-N'-nitro-N-nitrosoguanidine and taurocholate.
    Furihata C; Yamakoshi A; Hatta A; Tatematsu M; Iwata H; Hayashi K; Umezawa K; Matsushima T
    Cancer Lett; 1994 Aug; 83(1-2):215-20. PubMed ID: 8062219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
    Tang BD; Zeng ZR; Hu PJ
    Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Taurocholate-induced gastric damage in rats with obstructive jaundice.
    Matsuo T; Sasaki I; Kamiyama Y; Naitoh H; Funayama Y; Takahashi M; Fukushima K; Matsuno S
    Scand J Gastroenterol Suppl; 1989; 162():83-6. PubMed ID: 2595315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of gastric secretion on penetration of N-3H-methyl-N-nitro-N-nitrosoguanidine into gastric mucosa of rats.
    Ovrebø KK; Sørbye H; Kvinnsland S; Grong K; Svanes K
    Dig Dis Sci; 1998 Sep; 43(9):2012-20. PubMed ID: 9753267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acidification of arterial blood enhances gastric mucosal injury induced by bile salts in dogs.
    Cheung LY; Toenjes AA; Sonnenschein LA
    Am J Surg; 1982 Jan; 143(1):74-9. PubMed ID: 6797313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastric mucosal "barrier".
    Fromm D
    Gastroenterology; 1979 Aug; 77(2):396-8. PubMed ID: 447051
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of 16,16-dimethyl prostaglandin E2 on the gastric mucosal barrier.
    Bolton JP; Cohen MM
    Gut; 1979 Jun; 20(6):513-7. PubMed ID: 468078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aspirin- and taurocholate-induced metabolic damage in mammalian gastric mucosa in vitro.
    Ohe K; Hayashi K; Shirakawa T; Yamada K; Kawasaki T; Miyoshi A
    Am J Physiol; 1980 Dec; 239(6):G457-62. PubMed ID: 7446738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bile salt-induced gastric mucosal damage and histamine receptor antagonists.
    Lewi HJ; Carter DC
    Gut; 1983 Jan; 24(1):33-7. PubMed ID: 6848431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gastric mucosa permeability and HCO3- secretion 'in vivo' during perfusion of damaging and protective agents across canine Heidenhain pouches.
    Ventura U; Ceriani T; Moggio R
    Scand J Gastroenterol Suppl; 1984; 92():55-8. PubMed ID: 6204372
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bile acid-induced depolarization of mitochondrial membrane potential preceding cell injury in cultured gastric mucosal cells.
    Miura S; Fukumura D; Shiozaki H; Suzuki M; Kurose I; Suematsu M; Tsuchiya M; Ishii H
    J Gastroenterol Hepatol; 1995; 10(6):621-6. PubMed ID: 8580403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.